Late­com­er Am­gen takes 'plat­form ap­proach' in obe­si­ty as PhII da­ta loom

As Am­gen catch­es up with lead­ers in the bur­geon­ing obe­si­ty space, it’s un­der­scor­ing a “plat­form ap­proach” and shoot­ing for “broad op­tion­al­i­ty” in the de­sign of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER